ANA
LLUCH HERNANDEZ
EMÉRITO/A UNIVERSIDAD
![Foto de ANA](/img/nophoto.png)
![Foto de AstraZeneca (United Kingdom)](/img/noimage_org.png)
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoAstraZeneca (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2021
-
Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer
npj Breast Cancer, Vol. 7, Núm. 1